ResMed (RMD) July out of the money puts active as share price down 12%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Oppenheimer Downgrades ResMed (RMD) to Perform
June 25, 2024 6:02 AM EDTOppenheimer analyst Suraj Kalia downgraded ResMed (NYSE: RMD) from Outperform to Perform.
The analyst comments "SURMOUNT-OSA dataset was presented at ADA (NEJM link) on 06/21. While we have discussed GLP-1s/SURMOUNT-OSA at length and the risk we believe they represent to the... More
